On the recordApril 26, 2016
The challenges associated with developing treatments and the investments we make to develop novel medicines, that is really completely a red herring with respect to Syprine.
Source
congress.govThe challenges associated with developing treatments and the investments we make to develop novel medicines, that is really completely a red herring with respect to Syprine.
Kaine criticizes Valeant's justification for price increases on Syprine.
Share
More from Tim Kaine
Commodity prices have been sort of flat. All the input prices are going up, export markets are shutting down.
Everywhere we go throughout the Commonwealth, we hear the same thing: Virginians cannot afford this Administration’s disastrous policies.
The violence committed by Israeli settlers in the West Bank is reaching an unprecedented level, and as a result more and more Americans and Palestinians are being killed and injured. These actions – and the Israeli government’s lack of…
But they're finally listening to them. And nothing makes you listen as much as an election staring you in the face.